The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.60
Bid: 2.55
Ask: 2.65
Change: 0.075 (2.97%)
Spread: 0.10 (3.922%)
Open: 2.525
High: 2.65
Low: 2.525
Prev. Close: 2.525
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

2 Jun 2017 11:30

RNS Number : 0105H
Stockdale Securities Limited
02 June 2017
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stockdale Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brave Bison Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

As above

(d) Date dealing undertaken:

01 06 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Sale

36,944

1.34p

1.34p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

02 June 2017

Contact name:

Andrew Proctor

Telephone number:

0207 601 6106

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERZMGGVGZRGNZM
Date   Source Headline
26th May 20207:00 amRNSGrant of RSUs to a Director
18th May 20207:00 amRNSBrave Bison announces four global YouTube deals
6th May 20207:00 amRNSBoard Changes
4th May 20207:00 amRNSGrowth in KPIs following new publishing strategy
30th Apr 20205:00 pmRNSTotal Voting Rights
30th Apr 202012:10 pmRNSAcquisition of The Hook
22nd Apr 20205:12 pmRNSExercise of options and change to TVR
20th Apr 20205:55 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSDirector/PDMR Shareholding and Holding in Company
15th Apr 20207:00 amRNSFinal Results
27th Mar 20207:00 amRNSUpdate re Final Results and 2019 Annual Report
23rd Mar 20204:44 pmRNSHolding(s) in Company
4th Mar 20201:31 pmRNSBrave Bison appoints Exec VP & MD for JAPAC
24th Feb 20209:46 amRNSBrave Bison leads World Chase Tag online success
17th Feb 20207:00 amRNSAppointment of Non-Executive Director
10th Feb 20207:00 amRNSBBSN launches Slick on Snapchat to 40M viewers
5th Feb 20207:00 amRNSBoard Changes
31st Dec 201911:30 amRNSAppointment of Interim Chairman
20th Dec 20192:54 pmRNSAppointment of Non-Executive Director
20th Dec 20197:00 amRNSBoard Change
18th Dec 20192:28 pmRNSHolding(s) in Company
2nd Dec 20197:00 amRNSBrave Bison Announces Three New Senior Hires
28th Nov 20191:01 pmRNSHolding(s) in Company
26th Nov 20195:25 pmRNSBoard Change
25th Nov 20194:04 pmRNSHolding(s) in Company
22nd Nov 20197:00 amRNSBoard Change
22nd Nov 20197:00 amRNSTrading Update and Notice of Results
21st Nov 20193:35 pmRNSHolding(s) in Company
21st Nov 20192:50 pmRNSFurther Investment in Brave Bison Group plc
31st Oct 20195:00 pmRNSTotal Voting Rights
18th Oct 201912:26 pmRNSHolding(s) in Company
18th Oct 20197:00 amRNSExercise of options and issue of equity
10th Oct 20193:43 pmRNSHolding(s) in Company
3rd Oct 20191:35 pmRNSChange of Registered Office
25th Sep 20192:54 pmRNSExercise of Options and Issue of Equity
13th Sep 20193:38 pmRNSHolding(s) in Company
9th Aug 20197:00 amRNSAppointment of Non-Executive Director
6th Aug 201910:46 amRNSHolding(s) in Company
6th Aug 201910:45 amRNSFurther Investment in Brave Bison Group plc
31st Jul 20195:00 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSHalf-year Report
19th Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20194:19 pmRNSSixth Investment - Brave Bison Group plc
18th Jul 20193:32 pmRNSHolding(s) in Company
27th Jun 20195:18 pmRNSExercise of options and issue of equity
20th Jun 20197:00 amRNSHolding(s) in Company
19th Jun 201912:45 pmRNSResult of AGM
19th Jun 201910:22 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSAGM Statement
5th Jun 201911:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.